Cytokinetics | CYTK - Sales Revenues


Cytokinetics reported $1.93M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Acadia Pharmaceuticals USD 278.6M 14M Sep/2025
Amgen USD 9.9B 340M Dec/2025
Bayer EUR 9.66B 1.08B Sep/2025
Biogen USD 2.28B 250M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Cytokinetics USD 1.93M 64.83M Sep/2025
Eisai JPY 197.36B 5.29B Sep/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Exelixis USD 597.8M 29.5M Sep/2025
Geron USD 47.2M 1.8M Sep/2025
Halozyme Therapeutics USD 354M 148M Sep/2025
Ionis Pharmaceuticals USD 157M 295M Sep/2025
Ligand Pharmaceuticals USD 115.46M 67.83M Sep/2025
Merck USD 16.4B 880M Dec/2025
Novartis USD 13.91B 144M Sep/2025
Pfizer USD 17.58B 880M Dec/2025
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025